Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry|November 9, 2020
Redirecting cytotoxic T cells with chemically programmed antibodiesJunpeng Qi, Christoph RaderMethods (San Diego, Calif.)|August 27, 2018
An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignanciesJunpeng Qi, Shih-Shih Chen, Nicholas Chiorazzi, et al.Frontiers in Immunology|September 10, 2019
Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1Junpeng Qi, David Hymel, Christopher G Nelson, et al.Angewandte Chemie (International Ed. in English)|April 25, 2020
Chemically Programmable and Switchable CAR-T TherapyJunpeng Qi, Kohei Tsuji, David Hymel, et al.The Journal of Biological Chemistry|February 7, 2016
Targeting Stereotyped B Cell Receptors from Chronic Lymphocytic Leukemia Patients with Synthetic Antigen SurrogatesMohosin Sarkar, Yun Liu, Junpeng Qi, et al.The Journal of Biological Chemistry|March 21, 2020
Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applicationsRebecca S Goydel, Justus Weber, Haiyong Peng, et al.Proceedings of the National Academy of Sciences of the United States of America|May 31, 2018
Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1Junpeng Qi, Xiuling Li, Haiyong Peng, et al.Current Opinion in Biotechnology|December 17, 2019
Bispecific antibodies in cancer immunotherapyChristoph RaderCurrent Protocols in Protein Science|February 24, 2009
Overview on concepts and applications of Fab antibody fragmentsChristoph RaderPageof 16